Hepa BSV 100 IU Injection
Hepa BSV 100 IU Injection is a human hepatitis B immunoglobulin preparation used for passive immunization against the hepatitis B virus (HBV). It is derived from pooled human plasma containing high titers of antibodies against hepatitis B surface antigen (HBsAg) and is indicated for post-exposure prophylaxis in individuals at risk of HBV infection.
Contact us for sales assistance from our Biomedical Engineer.
Features:
-
Contains Hepatitis B-specific antibodies (100 IU)
-
Offers immediate passive immunity
-
Used in newborns of infected mothers, healthcare exposure, or after unprotected contact with HBV
-
Manufactured from screened, virus-inactivated human plasma
-
Suitable for use alongside Hepatitis B vaccine in certain protocols
-
Strict quality control ensuring high purity and safety
-
Packaged in a 0.5 mL single-dose vial
| Technical Specification |
|
|---|
- 1 x 0.5 ML VIAL
-
rovides immediate protection against hepatitis B after exposure
-
Can be used for neonates born to HBsAg-positive mothers
-
Useful in accidental needle-stick injuries or mucosal exposure
-
Helps prevent hepatitis B transmission before vaccine immunity develops
-
Manufactured under WHO-GMP certified facility with rigorous plasma safety measures
-
Safe and well-tolerated with minimal side effects under clinical supervision
